Lyell Immunopharma to Participate in Goldman Sachs, Stifel and Jefferies Investor Events

PUBT · 3d ago
Lyell Immunopharma to Participate in Goldman Sachs, Stifel and Jefferies Investor Events
  • Lyell Immunopharma will join Goldman Sachs' RxChange fireside chat on lymphoma CAR-T data Nov. 5, 2026, at 11 a.m. ET.
  • Management will participate in a Stifel Healthcare Conference fireside chat Nov. 10, 2026, at 4 p.m. ET, alongside one-on-one meetings.
  • The team will attend one-on-one meetings at the Jefferies Global Healthcare Conference Nov. 18, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020800PRIMZONEFULLFEED9867903) on November 02, 2026, and is solely responsible for the information contained therein.